Candiolo Cancer Institute - FPO, IRCCS

Site:	Candiolo Cancer Institute - FPO, IRCCS
Address:
City:	Turin
State:
Zip:
Country:	Italy

Phase	Trial	Trial Status [desc]	Site Status	Drug	NCT#
3	Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST	Active, not recruiting	Closed	Crenolanib (CP-868,596)	NCT02847429